NEUROFIBROMATOSIS INC NORTHEAST

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

1999–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	6	2
2008	—	4	1
2007	—	2	1
2006	—	1	1
2005	—	2	1
2003	—	1	1
2002	—	2	1
2001	—	2	1
2000	—	2	1
1999	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
VAN SCOYOC ASSOCIATES	—	72
CAPITOL ASSOCIATES, INC.	—	19

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	88
SENATE	87
Defense, Dept of (DOD)	47
Natl Institutes of Health (NIH)	15
Health & Human Services, Dept of (HHS)	13
Veterans Affairs, Dept of (VA)	7
Education, Dept of	4
Army, Dept of (Other)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	91
Defense	Defense	46

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 9260119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

2026 · third_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.9495, Department of Defense Appropriations Act, 2027 H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Client expense: — · Firm income: —

Matched citations: H.R.9260

H.R. 9495119th Congress

Department of Defense Appropriations Act, 2027

2026 · third_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.9495, Department of Defense Appropriations Act, 2027 H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Client expense: — · Firm income: —

Matched citations: H.R.9495

H.R. 9495119th Congress

Department of Defense Appropriations Act, 2027

2026 · third_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

H.R.9495, Department of Defense Appropriations Act, 2027, Medical research issues and Neurofibromatosis provisions

Client expense: — · Firm income: —

Matched citations: H.R.9495

H.R. 9260119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

2026 · second_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.9495, Department of Defense Appropriations Act, 2027 H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Client expense: — · Firm income: —

Matched citations: H.R.9260

Show 21 more cited filings

H.R. 9495119th Congress

Department of Defense Appropriations Act, 2027

2026 · second_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.9495, Department of Defense Appropriations Act, 2027 H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Client expense: — · Firm income: —

Matched citations: H.R.9495

H.R. 9495119th Congress

Department of Defense Appropriations Act, 2027

2026 · second_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

H.R.9495, Department of Defense Appropriations Act, 2027, Medical research issues and Neurofibromatosis provisions

Client expense: — · Firm income: —

Matched citations: H.R.9495

H.R. 4016119th Congress

Department of Defense Appropriations Act, 2026

2025 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026, Medical research issues and Neurofibromatosis provisions

Client expense: — · Firm income: —

Matched citations: H.R.4016

H.R. 4016119th Congress

Department of Defense Appropriations Act, 2026

2025 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026 H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: H.R.4016

H.R. 5304119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2025 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026 H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: H.R.5304

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026, Medical research issues and Neurofibromatosis provisions

Client expense: — · Firm income: —

Matched citations: S.2572

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026 H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: S.2572

S. 2587119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2025 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026 H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: S.2587

H.R. 4016119th Congress

Department of Defense Appropriations Act, 2026

2025 · third_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026, Medical research issues and Neurofibromatosis provisions

Client expense: — · Firm income: —

Matched citations: H.R.4016

H.R. 4016119th Congress

Department of Defense Appropriations Act, 2026

2025 · third_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026 H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: H.R.4016

H.R. 5304119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2025 · third_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026 H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: H.R.5304

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · third_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026 H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: S.2572

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · third_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026, Medical research issues and Neurofibromatosis provisions

Client expense: — · Firm income: —

Matched citations: S.2572

S. 2587119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2025 · third_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026 H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: S.2587

H.R. 4016119th Congress

Department of Defense Appropriations Act, 2026

2025 · second_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-4, Full-Year Continuing Appropriations and Extensions Act, FY2025 H.R.4016, Department of Defense Appropriations Act, FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: H.R.4016

H.R. 4016119th Congress

Department of Defense Appropriations Act, 2026

2025 · second_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-4, Full-Year Continuing Appropriations and Extensions Act, FY2025 H.R.4016, Department of Defense Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: H.R.4016

H.R. 8774119th Congress

Bulletproof Law Enforcement Vehicles Act

2025 · first_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-4, Full-Year Continuing Appropriations and Extensions Act, FY2025 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 Department of Defense Appropriations Act, FY2026 H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: H.R.8774

H.R. 8774119th Congress

Bulletproof Law Enforcement Vehicles Act

2025 · first_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-4, Full-Year Continuing Appropriations and Extensions Act, FY2025 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 Department of Defense Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: H.R.8774

H.R. 9029119th Congress

Coal Cleanup Taxpayer Protection Act of 2026

2025 · first_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-4, Full-Year Continuing Appropriations and Extensions Act, FY2025 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 Department of Defense Appropriations Act, FY2026 H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: H.R.9029

S. 4921119th Congress

Blair Holt Firearm Owner Licensing and Record of Sale Act of 2026

2025 · first_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-4, Full-Year Continuing Appropriations and Extensions Act, FY2025 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 Department of Defense Appropriations Act, FY2026 H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: S.4921

S. 4921119th Congress

Blair Holt Firearm Owner Licensing and Record of Sale Act of 2026

2025 · first_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-4, Full-Year Continuing Appropriations and Extensions Act, FY2025 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 Department of Defense Appropriations Act, FY2026

Client expense: — · Firm income: —

Matched citations: S.4921

Source: Senate LDA

NEUROFIBROMATOSIS INC NORTHEAST — Lobbying Disclosure | Poliscope